Health-care stocks haven't gotten the green light many expected from Hillary Clinton's election loss.
Jim Cramer takes on a lightning round of stocks and quickly provides his opinion on how to play them.
Jim Cramer advised investors to avoid ringing the register, yet.
President-elect Trump's time in the White House could be beneficial to a group of domestic stocks.
In the likely repeal of the Affordable Care Act, these health-care stocks should perform well, according to some analysts.
Pharmaceutical companies don't expect President-elect Donald Trump to continue the tough rhetoric on drug prices.
Some of the names on the move ahead of the open.
Amgen's migraine drug meets its clinical trial goal. CNBC's Meg Tirrell reports.
Health-care companies saw their stocks shoot through the roof on Wednesday after Republican Donald Trump's shocking White House victory.
Boris Schlossberg, Managing Director of FX Strategy, BK Asset Management, and Ari Wald, Oppenheimer, look at the post-election market surge.
Trump has promised that one of the first things he will do as president is to repeal Obamacare. What would that look like?
CNBC's Meg Tirrell reports the latest surrounding California's Proposition 61. The "Fast Money" traders weigh in.
More than $125 million has been spent over an initiative to bar state agencies from paying more for drugs than the Veterans Affairs Department pays.
The "Fast Money" traders give you 3 ways to play the contentious election this Tuesday.
Pharmaceutical stocks have been under pressure, but certain companies are doing things right, former Medtronic CEO Bill George says.
Eric Marshall, Hodges Small Cap Fund Co-Portfolio Manager, and Nancy Tengler, Heartland Financial CIO, discuss the market uncertainty surrounding the election, and how to play it.
Pfizer reported a drop in income, largely due to an impairment charge related to the pending sale of its Hospira infusion therapy business.
CNBC's Meg Tirrell takes a closer look at the sell-off of healthcare and biotech stocks.
Michael Yee, RBC Capital Markets biotech analyst, discusses the election's impact on biotech, and his take on Amgen.
The “Fast Money Halftime Report” traders and Kourtney Gibson, Loop Capital president, share their takes on the healthcare sector.